After World-Leading Vaccine Roll-Out, UK Eyes Booster Phase But Faces Pressure To Help Globe
Executive Summary
The UK’s purchase of 60 million extra Pfizer/BioNTech COVID vaccine doses, plus bets on Novavax and Valneva and others gives it a buffer against new variants – so when will it pledge to donate to more needy nations?